Topographic Localization of Chronic Cerebellar Ischemic Lesions: Implications for Underlying Cause
- PMID: 40177749
- DOI: 10.1161/STROKEAHA.124.049337
Topographic Localization of Chronic Cerebellar Ischemic Lesions: Implications for Underlying Cause
Abstract
Background: Chronic cerebellar lesions of presumed ischemic origin are frequently found in patients with ischemic stroke and as incidental findings. However, the differentiation of embolic lesions from lesions caused by cerebral small vessel disease (SVD) is unclear. We aimed to investigate whether the location of chronic cerebellar ischemic lesions (deep versus cortical) indicates the underlying cause (embolic versus SVD).
Methods: This study was a post hoc data analysis from the multinational ELAN trial (Early Versus Late Initiation of Direct Oral Anticoagulants in Patients With Postischemic Stroke With Atrial Fibrillation), which included patients with acute ischemic stroke and atrial fibrillation cohort between 2017 and 2022. For comparison, data from 2 cohorts (DiViNAS [Disease Variability in NOTCH3-Associated SVD] and VASCAMY [Vascular and Amyloid Predictors of Neurodegeneration and Cognitive Decline in Nondemented Subjects]) consisting of participants with hereditary cerebral SVD (ie, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) were analyzed (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy cohort). Brain magnetic resonance imaging scans were evaluated for presence and location of chronic cerebellar ischemic lesions. The association between these lesions and the severity of supratentorial SVD was analyzed using univariable and multivariable models, adjusting for key covariables.
Results: In the atrial fibrillation cohort (N=790), 278 (35%) patients had chronic cerebellar ischemic lesions (cortical: n=242; deep: n=36). In multivariable analyses, features of cerebral SVD were associated with deep cerebellar ischemic lesions (summary SVD score; odds ratio per point, 2.5 [95% CI, 1.5-3.5]; P<0.001), while there was no association of SVD markers and cortical cerebellar ischemic lesions (summary SVD score; odds ratio per point, 1.1 [95% CI, 0.9-1.3]; P=0.107). In the cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy cohort (N=257), chronic cerebellar ischemic lesions (n=108 [42%]) were almost exclusively identified in deep cerebellar regions (n=101, 94%).
Conclusions: Chronic cerebellar ischemic lesions in deep but not cortical regions were associated with supratentorial cerebral SVD. Therefore, cerebral SVD is likely the primary cause of chronic ischemic lesions in deep cerebellar regions, while cortical cerebellar lesions are more likely attributable to embolic etiologies.
Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03148457.
Keywords: atrial fibrillation; brain; cerebral infarction; ischemic stroke; magnetic resonance imaging.
Conflict of interest statement
Dr Kneihsl received a grant from the European Academy of Neurology, not related to the submitted work, and has served on advisory boards of Novartis and BMS Pfizer. Dr Hakim reports grants from Schweizerische Herzstiftung. Dr Goeldlin reports grants from Inselspital Bern University Hospital, the Swiss Stroke Society, Mittelbauvereinigung Universitaet Bern, the European Stroke Organisation, and Gottfried und Julia Bangerter-Rhyner-Stiftung and travel support from the European Academy of Neurology. Dr Gattringer reports travel support from Boehringer Ingelheim, Bayer, and Novartis; compensation from Amgen and Bristol Myers Squibb for other services; and grants from the Austrian Science Fund. Dr Dawson reports compensation from Medtronic, Bristol Myers Squibb, and Daiichi Sankyo Company for other services and grants from the Stroke Association. Dr Kopczak is supported by the Vascular Dementia Research Foundation and the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy: ID 390857198). Dr Cerfontaine reports grants from Hersenstichting and from the Netherlands Organisation for Health Research and Development. Dr Rutten reports grants from The Brain Foundation of the Netherlands and the Netherlands Institute of Government. Dr Lesnik Oberstein reports grants from The Netherlands Brain Foundation and the Netherlands Organisation for Health Research and Development. Dr Fischer reports grants from Schweizerische Herzstiftung and the Swiss National Science Foundation. Dr Meinel reports grants from the Baasch-Medicus Foundation, the Bangerter-Rhyner Foundation, the Swiss Heart Foundation, the Swiss National Science Foundation, University Bern, and Inselspital Bern. The other authors report no conflicts.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous